| Advanz Pharma Specialty Medicine Switzerland GmbH - Gobivaz 100 mg/1 ml, Injektionslösung in einer Fertigspritze |
| 70709 | | 01 | | Gobivaz 100 mg/1 ml | | Injektionslösung in einer Fertigspritze | | L04AB06 | | Golimumab | | 30.07.2026 | | |
|
| Composition |
| golimumabum 100 mg, histidinum, histidini hydrochloridum monohydricum, sorbitolum 41 mg, poloxamerum 188, aqua ad iniectabile q.s. ad solutionem pro 1 ml. |
| Packungsbestandteile |
| Injection solution in prefilled syringe | | | | | | Active Agent | Dose |
|---|
| Golimumabum | 100 mg/ml |
| | | | Inactive agents | Dose |
|---|
| Histidin Hydrochloride Monohydrate | | | Histidine | | | Poloxamer | 188 | | Sorbitol | 41 mg/ml |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 003 | | | | B | | Yes | | 004 | 3 | | | B | | Yes |
|
